Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
复制标题
GATA6 和组蛋白脱乙酰酶抑制剂存在下协同诱导移行细胞癌中的 DOC-2/DAB2 基因表达。
DOI:
10.1158/0008-5472.can-04-3672
复制
发表时间:
2005
期刊:
影响因子:
11.2
通讯作者:
Hsieh,Jer-Tsong
中科院分区:
文献类型:
--
作者:
Zhou,Jian;Hernandez,Gina;Tu,Szu-Wei;Scholes,Jessica;Chen,Hong;Tseng,Ching-Ping;Hsieh,Jer-Tsong
The down-regulation ofDOC-2/DAB2gene, which encodes a unique phosphoprotein modulating signal pathways elicited by exogenous stimuli, is often associated with several cancer types; however, the underlying mechanism is still unknown. Dramatically different expression levels of DOC-2/DAB2 mRNA and protein are observed among several human transitional cell carcinoma (TCC) cell lines, suggesting that transcriptional regulation may play a role in these cells. In this study, we have shown that the histone acetylation status associated with the 5′ upstream regulatory sequence ofDOC-2/DAB2gene is one of the key determinants for its gene expression. In addition, GATA6 but not other GATA family members, such as GATA2 and GATA4, can specifically induceDOC-2/DAB2promoter activity, although GATA transcription factors share a very similar DNA-binding sequence. We also show that increased histone acetylation and the presence of GATA6 have a synergistic effect onDOC-2/DAB2promoter activity, which results in the elevation of DOC-2/DAB2 protein expression. Thus, we conclude that transcriptional regulation ofDOC-2/DAB2gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., GATA6), which underlie the reduced DOC-2/DAB2 protein expression in TCC cells.